Hamburg outlines anti-counterfeiting measures; BMS's Orencia measured up to Humira in study;

 @FiercePharma: Pfizer plans IPO for minority stake in animal-health unit--dubbed "Zoetis"--on its way to total spinoff. Report | Follow @FiercePharma

> To fight drug counterfeiting, FDA Commissioner Margaret Hamburg called for increased penalties, global co-operation among regulators, and more supply-chain vigilance on the part of drugmakers. Report

> Bristol-Myers Squibb's ($BMY) Orencia proved comparable to Abbott Laboratories' ($ABT) Humira at treating rheumatoid arthritis patients new to biologic treatments. News

> UCB bolstered its case for four-week dosing of Cimzia in rheumatoid arthritis with data showing comparable efficacy to two-week regimen. Article

> Anti-TNF drugs can increase the risk of shingles by 75% in patients with inflammatory rheumatic diseases, a study found. Item

> U.S. marshals seized unapproved drug products from a company warehouse in Portland, ME. More

> The FDA warned 8 biopharma companies, 6 of them in the Asia Pacific region, for importing drugs into the U.S. without registering their manufacturing plants. Story

> Pharmaxis failed to win the U.K. cost-effectiveness watchdog's backing for its cystic fibrosis drug Bronchitol. Report

Biotech News

 @FierceBiotech: Catalent continues restructuring efforts as it completes work on NC fill-finish plant. News | Follow @FierceBiotech

 @RyanMFierce: My post about how Lilly leads docs to cancer drug trials with iPad app. Article | Follow @RyanMFierce

> Sanofi's Zerhouni rewrites the company playbook on R&D. Report

> Fledgling Foundation Medicine scores a coup with Novartis R&D pact. News

> Otsuka cracks tough TB cases with experimental drug. More

> Lilly chief resolves to stick with high-risk pipeline strategy. Item

Medical Devices News

 @FierceMedDev: Only a few weeks left to submit your nominations for the 15 fiercest private device developers. Survey | Follow @FierceMedDev

> Device tax repeal up for House vote today as White House threatens veto. Item

> Mindray snaps up Chinese orthopedics maker for $35.5M. Story

> Report: Panasonic to become major Olympus shareholder with $635M investment. More

CRO News

 @NesaNFierce: Catalent's renovated fill-finish plant in NC is more in-tune with the company's renewed business focus. Article | Follow @NesaNFierce

> Siegfried buys Allied Medical Products for $58M. News

> Medtox's toxicology offerings contribute to LabCorp acquisition, as contract manufacturing shrinks. More

> WuXi PharmaTech speaks out on compound theft by former employee. Article

> Kansas City CROs form alliance to attract outsourcing work to region. Item

Pharma Manufacturing News

> FDA commish suggests drugmakers get on board with track and trace. More

> Sandoz recalls Introvale contraceptives. News

> Indian API maker looks to Asia for cheap energy. Report

Vaccines News

> NewLink Genetics takes the stage at ASCO. Story

> Vax, hormone combo could up efficacy in prostate cancer. Article

> Mapping the way to a Candida vaccine. Item

> Affiris' Parkinson's therapeutic vax starts clinical trials. More

And Finally... Analysis of a pregnant mother's blood and father's saliva yielded a full-genome sequence of their unborn child. Report